Biologically Active Small Molecules

A selective CB1 receptor agonist exhibiting Ki values of 21.2 nM and &gt3 &microM at the CB1 and CB2 receptors, respectively more chemically stable than 2-AG, with an endogenous half-life of hours rather than minutes but 10-fold less potent than

A selective CB1 receptor agonist exhibiting Ki values of 21.2 nM and &gt3 &microM at the CB1 and CB2 receptors, respectively more chemically stable than 2-AG, with an endogenous half-life of hours rather than minutes but 10-fold less potent than

A selective CB1 receptor agonist exhibiting Ki values of 21.2 nM and &gt3 &microM at the CB1 and CB2 receptors, respectively more chemically stable than 2-AG, with an endogenous half-life of hours rather than minutes but 10-fold less potent than

A selective CB1 receptor agonist exhibiting Ki values of 21.2 nM and &gt3 &microM at the CB1 and CB2 receptors, respectively more chemically stable than 2-AG, with an endogenous half-life of hours rather than minutes but 10-fold less potent than

2-carboxy-Pyrimidine is a synthetic intermediate useful for pharmaceutical synthesis.

2-carboxy-Pyrimidine is a synthetic intermediate useful for pharmaceutical synthesis.

2-carboxy-Pyrimidine is a synthetic intermediate useful for pharmaceutical synthesis.

A stable analog of adenosine that acts as an agonist for adenosine receptors (Ki = 0.3, 0.

A stable analog of adenosine that acts as an agonist for adenosine receptors (Ki = 0.3, 0.

A stable analog of adenosine that acts as an agonist for adenosine receptors (Ki = 0.3, 0.

A conjugate of CNP and &alpha-D-glucose, to be used as a chromogenic substrate for enzymes that target the linkage between CNP and &alpha-D-glucose.

A conjugate of CNP and &alpha-D-glucose, to be used as a chromogenic substrate for enzymes that target the linkage between CNP and &alpha-D-glucose.